These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36893971)

  • 1. Comparative efficacy of sulphadoxine-pyrimethamine and dihydroartemisinin-piperaquine against malaria infection during late-stage pregnancy in mice.
    Akinola O; Ategbero E; Amusan AI; Gbotosho GO
    Exp Parasitol; 2023 May; 248():108500. PubMed ID: 36893971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of chloroquine and sulphadoxine-pyrimethamine either alone or in combination before introduction of ACT as first-line therapy in uncomplicated Plasmodium falciparum malaria in Jalpaiguri District, West Bengal, India.
    Mullick S; Das S; Guha SK; Bera DK; Sengupta S; Roy D; Saha P; Biswas A; Das M; Ray K; Kundu PK; Maji AK
    Trop Med Int Health; 2011 Aug; 16(8):929-35. PubMed ID: 21564429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisinin-naphthoquine combination (ARCO) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacy.
    Hombhanje FW; Linge D; Saweri A; Kuanch C; Jones R; Toraso S; Geita J; Masta A; Kevau I; Hiawalyer G; Sapuri M
    Malar J; 2009 Aug; 8():196. PubMed ID: 19671190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of pregnant BALB/c mice with sulphadoxine pyrimethamine or chloroquine abrogates Plasmodium berghei induced placental pathology.
    Sharma L; Shukla G
    Parasitol Int; 2014 Feb; 63(1):49-56. PubMed ID: 24013006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
    Swarthout TD; van den Broek IV; Kayembe G; Montgomery J; Pota H; Roper C
    Trop Med Int Health; 2006 Oct; 11(10):1503-11. PubMed ID: 17002724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
    Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
    P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic efficacy of chloroquine plus sulphadoxine/ pyrimethamine compared with monotherapy with either chloroquine or sulphadoxine/pyrimethamine in uncomplicated Plasmodium falciparum malaria in Laos.
    Schwöbel B; Jordan S; Vanisaveth V; Phetsouvanh R; Christophel EM; Phompida S; von Sonnenburg F; Jelinek T
    Trop Med Int Health; 2003 Jan; 8(1):19-24. PubMed ID: 12535245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of malaria parasite resistance to chloroquine and sulphadoxine-pyrimethamine in the Solomon Islands by DNA microarray technology.
    Ballif M; Hii J; Marfurt J; Crameri A; Fafale A; Felger I; Beck HP; Genton B
    Malar J; 2010 Oct; 9():270. PubMed ID: 20925934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the parasite killing effect of artemisinin combination therapy in a murine malaria model.
    Patel K; Batty KT; Moore BR; Gibbons PL; Kirkpatrick CM
    J Antimicrob Chemother; 2014 Aug; 69(8):2155-63. PubMed ID: 24777899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced antimalarial effects of chloroquine by aqueous Vernonia amygdalina leaf extract in mice infected with chloroquine resistant and sensitive Plasmodium berghei strains.
    Iwalokun BA
    Afr Health Sci; 2008 Mar; 8(1):25-35. PubMed ID: 19357729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon.
    Whegang SY; Tahar R; Foumane VN; Soula G; Gwét H; Thalabard JC; Basco LK
    Malar J; 2010 Feb; 9():56. PubMed ID: 20170477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi.
    Schultz LJ; Steketee RW; Macheso A; Kazembe P; Chitsulo L; Wirima JJ
    Am J Trop Med Hyg; 1994 Nov; 51(5):515-22. PubMed ID: 7985742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloroquine resistant Plasmodium falciparum malaria in Osogbo Nigeria: efficacy of amodiaquine + sulfadoxine-pyrimethamine and chloroquine + chlorpheniramine for treatment.
    Ogungbamigbe TO; Ojurongbe O; Ogunro PS; Okanlawon BM; Kolawole SO
    Mem Inst Oswaldo Cruz; 2008 Feb; 103(1):79-84. PubMed ID: 18368238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control.
    Verhoeff FH; Brabin BJ; Hart CA; Chimsuku L; Kazembe P; Broadhead RL
    Trop Med Int Health; 1999 Jan; 4(1):5-12. PubMed ID: 10203167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimalarials during pregnancy: a cost-effectiveness analysis.
    Schultz LJ; Steketee RW; Chitsulo L; Wirima JJ
    Bull World Health Organ; 1995; 73(2):207-14. PubMed ID: 7743592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether-lumefantrine in eastern Sudan.
    Mukhtar EA; Gadalla NB; El-Zaki SE; Mukhtar I; Mansour FA; Babiker A; El-Sayed BB
    Malar J; 2007 Jul; 6():92. PubMed ID: 17631681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.
    Kinzer MH; Chand K; Basri H; Lederman ER; Susanti AI; Elyazar I; Taleo G; Rogers WO; Bangs MJ; Maguire JD
    Malar J; 2010 Apr; 9():89. PubMed ID: 20370920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
    Gogtay N; Kannan S; Thatte UM; Olliaro PL; Sinclair D
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD008492. PubMed ID: 24163021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.
    Tekete M; Djimde AA; Beavogui AH; Maiga H; Sagara I; Fofana B; Ouologuem D; Dama S; Kone A; Dembele D; Wele M; Dicko A; Doumbo OK
    Malar J; 2009 Feb; 8():34. PubMed ID: 19245687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.